½ÃÀ庸°í¼­
»óǰÄÚµå
1629296

¼¼°èÀÇ Ç¥Àû ½ÃÄö½Ì ¹× ¸®½ÃÄö½Ì ½ÃÀå : ±â¼úº°, À¯Çüº°, ¿ëµµº°, ÃÖÁ¾»ç¿ëÀÚº°, ±¹°¡º°, Áö¿ªº° - »ê¾÷ ºÐ¼®, ½ÃÀå ±Ô¸ð ¹× Á¡À¯À², ¿¹Ãø(2025-2032³â)

Targeted Sequencing and Resequencing Market, By Technology, By Type, By Application, By End-User, By Country, and By Region - Global Industry Analysis, Market Size, Market Share & Forecast from 2025-2032

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: AnalystView Market Insights | ÆäÀÌÁö Á¤º¸: ¿µ¹® 355 Pages | ¹è¼Û¾È³» : 2-3ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

º¸°í¼­ ÇÏÀ̶óÀÌÆ®

Ç¥Àû ½ÃÄö½Ì¡¤¸®½ÃÄö½Ì ½ÃÀå ±Ô¸ð´Â 2024³â¿¡ 61¾ï 2,467¸¸ ´Þ·¯¿¡ ´ÞÇϸç, 2025-2032³â¿¡ CAGR 22.6%·Î È®´ë

Ÿ±ê ½ÃÄö½Ì ¹× ¸®½ÃÄö½Ì ½ÃÀå ¿ªÇÐ

¸ÂÃãÇü ÀÇ·á¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡·Î Ÿ±ê ½ÃÄö½Ì ¹× ¸®½ÃÄö½Ì ½ÃÀå ¼ºÀå ÁÖµµ

¸ÂÃãÇü ÀÇ·á¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡´Â Ÿ±ê ½ÃÄö½Ì ¹× ¸®½ÃÄö½Ì ½ÃÀå È®´ë¿¡ ¹ÚÂ÷¸¦ °¡Çϰí ÀÖ½À´Ï´Ù. À¯Àüü ±â¼úÀÇ ¹ß´Þ·Î Á¤È®ÇÑ È¯ÀÚ ºÐ·ù¿Í ¾à¹° °³¹ßÀÌ °¡´ÉÇØÁ³½À´Ï´Ù. ¹Ì±¹ ±¹¸³º¸°Ç¿ø(NIH)Àº °³ÀÎ ¸ÂÃãÇü Ä¡·á¸¦ Áö¿øÇϱâ À§ÇØ À¯Àüü ¿¬±¸¿¡ ¸·´ëÇÑ ÅõÀÚ¸¦ Çϰí ÀÖÀ¸¸ç, 2020³â¿¡¸¸ 2¾ï ´Þ·¯ ÀÌ»óÀÇ ¿¬±¸ºñ¸¦ ¹èÁ¤Çß½À´Ï´Ù. ÀÌ·¯ÇÑ ¿¬±¸ÀÇ ±ÞÁõÀº º¸´Ù Á¤È®ÇÑ Áø´Ü ¹× Ä¡·á ÅøÀÇ °³¹ß¿¡ µµ¿òÀÌ µÇ°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ Å¸±ê ½ÃÄö½ÌÀº Á¾¾çÇп¡¼­ ¸Å¿ì Áß¿äÇÑ ¿ªÇÒÀ» Çϰí ÀÖÀ¸¸ç, ÀÓ»ó½ÃÇè¿¡¼­ Ç¥Àû Ä¡·á°¡ »ýÁ¸À²À» Çâ»ó½ÃŰ´Â °ÍÀ¸·Î ³ªÅ¸³µ½À´Ï´Ù. ¶ÇÇÑ °³ÀÎÀÇ À¯ÀüÀÚ ÇÁ·ÎÆÄÀÏ¿¡ µû¶ó Ä¡·á¸¦ Á¶Á¤ÇÏ·Á´Â ÀÇ·á±â°üÀÇ Áö¼ÓÀûÀÎ ³ë·ÂÀº Ÿ±ê ½ÃÄö½ÌÀÇ Ã¤ÅÃÀ» ÃËÁøÇÏ¿© ¾Ï ¹× Èñ±Í À¯Àü Áúȯ¿¡¼­ ´õ ³ªÀº Ä¡·á °á°ú¸¦ ´Þ¼ºÇÏ´Â µ¥ µµ¿òÀ» ÁÖ°í ÀÖ½À´Ï´Ù.

Ÿ±ê ½ÃÄö½Ì ¹× ¸®½ÃÄö½Ì ½ÃÀå : ÁÖ¿ä °í·Á»çÇ×

´ç»çÀÇ ¸®¼­Ä¡ ¾Ö³Î¸®½ºÆ®µéÀÌ °øÀ¯ÇÑ ºÐ¼®¿¡ µû¸£¸é ¼¼°è ½ÃÀåÀº ¿¹Ãø ±â°£(2025-2032) µ¿¾È ¾à 22.6%ÀÇ ¿¬Æò±Õ º¹ÇÕ ¼ºÀå·ü(CAGR)·Î ¸Å³â ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

±â¼úº°·Î´Â ½ÃÄö½Ì ±â¼úÀÌ 2024³â °¡Àå Å« ½ÃÀå Á¡À¯À²À» º¸ÀÏ °ÍÀ¸·Î ¿¹ÃøµÇ¾ú½À´Ï´Ù.

À¯Çüº°·Î´Â DNA ±â¹Ý Ÿ±ê ½ÃÄö½ÌÀÌ 2024³â ÁÖ¿ä À¯ÇüÀ¸·Î ²ÅÇû½À´Ï´Ù.

¿ëµµº°·Î´Â ÀÓ»ó¿ëÀÌ 2024³â ÁÖ¿ä ¿ëµµ¿´½À´Ï´Ù.

Áö¿ªº°·Î´Â ºÏ¹Ì°¡ 2024³â ÁÖ¿ä ¼öÀÔ¿øÀ̾ú½À´Ï´Ù.

Ÿ±ê ½ÃÄö½Ì ¹× ¸®½ÃÄö½Ì ½ÃÀå : ¼¼ºÐÈ­ ºÐ¼®

¼¼°è Ÿ±ê ½ÃÄö½Ì ¹× ¸®½ÃÄö½Ì ½ÃÀåÀº ±â¼ú, À¯Çü, ¾ÖÇø®ÄÉÀ̼Ç, ÃÖÁ¾»ç¿ëÀÚ, Áö¿ª¿¡ µû¶ó ¼¼ºÐÈ­µË´Ï´Ù.

½ÃÀåÀº ±â¼ú¿¡ µû¶ó ½ÃÄö½Ì°ú ¸®½ÃÄö½ÌÀÇ µÎ °¡Áö ¹üÁÖ·Î ³ª´¹´Ï´Ù. ½ÃÄö½ÌÀº ÀÓ»ó Áø´Ü ¹× ¿¬±¸¿¡ ±¤¹üÀ§ÇÏ°Ô Àû¿ëµÇ¾î °¡Àå ³ôÀº ½ÃÀå Á¡À¯À²À» Â÷ÁöÇϰí ÀÖ½À´Ï´Ù. Àç¿°±â¼­¿­ ºÐ¼®Àº À¯ÀüÀÚ º¯ÀÌ¿¡ ´ëÇÑ Áß¿äÇÑ ÀλçÀÌÆ®À» Á¦°øÇÏ¿© ¸ÂÃãÇü ÀÇ·á ¹× Áúº´ °ü¸®¿¡ µµ¿òÀÌ µË´Ï´Ù.

½ÃÀåÀº DNA ±â¹Ý Ÿ±ê ½ÃÄö½Ì°ú RNA ±â¹Ý Ÿ±ê ½ÃÄö½ÌÀÇ µÎ °¡Áö ¹üÁÖ·Î ³ª´µ¸ç, DNA ±â¹Ý Ÿ±ê ½ÃÄö½ÌÀº À¯ÀüÀÚ ºÐ¼® ¹× Áúº´ °ËÃâ¿¡ ±¤¹üÀ§ÇÏ°Ô »ç¿ëµÇ¾î ¼±µÎ¸¦ ´Þ¸®°í ÀÖÀ¸¸ç, RNA ±â¹Ý Ÿ±ê ½ÃÄö½ÌÀº ƯÈ÷ ¾Ï ¿¬±¸ ¹× ÀǾàǰ °³¹ß¿¡ Áß¿äÇÑ ÀλçÀÌÆ®À» Á¦°øÇÕ´Ï´Ù. Àº ƯÈ÷ ¾Ï ¿¬±¸ ¹× ÀǾàǰ °³¹ß¿¡¼­ À¯ÀüÀÚ ¹ßÇö°ú Á¶Àý¿¡ ´ëÇÑ Áß¿äÇÑ ÀλçÀÌÆ®À» Á¦°øÇÕ´Ï´Ù.

Ÿ±ê ½ÃÄö½Ì ¹× ¸®½ÃÄö½Ì ½ÃÀå : Áö¿ªº° ºÐ¼®

Ÿ±ê ½ÃÄö½Ì ¹× ¸®½ÃÄö½Ì ½ÃÀåÀº À¯ÀüüÇÐ ¹× ¸ÂÃãÀÇ·áÀÇ ¹ßÀü¿¡ ÈûÀÔ¾î ´Ù¾çÇÑ Áö¿ª¿¡¼­ °­·ÂÇÑ ¼ºÀå¼¼¸¦ º¸À̰í ÀÖ½À´Ï´Ù. ºÏ¹Ì°¡ °¡Àå Å« ½ÃÀå Á¡À¯À²À» Â÷ÁöÇϰí Àִµ¥, ÀÌ´Â ÁÖ·Î ÁÖ¿ä »ý¸í°øÇÐ ±â¾÷ÀÇ Á¸Àç, ¹Ì±¹ ±¹¸³º¸°Ç¿ø(NIH)°ú °°Àº ±â°üÀÇ °­·ÂÇÑ ¿¬±¸ ÀÚ±Ý Áö¿ø, ¾Ï Ä¡·á¿¡¼­ Ç¥Àû Ä¡·áÀÇ Ã¤Åà Ȯ´ë¿¡ ±âÀÎÇÕ´Ï´Ù. ¹Ì±¹Àº Áß¿äÇÑ ±â¾÷À̸ç, Á¤¹ÐÀÇ·á¿¡ ´ëÇÑ ¸·´ëÇÑ ÅõÀÚ°¡ ÀÌ Áö¿ªÀÇ ¿ìÀ§¿¡ ±â¿©Çϰí ÀÖ½À´Ï´Ù. À¯·´µµ Áß¿äÇÑ ¿ªÇÒÀ» Çϰí ÀÖÀ¸¸ç, µ¶ÀÏ, ¿µ±¹, ÇÁ¶û½º¿Í °°Àº ±¹°¡µéÀÌ À¯Àüü ¿¬±¸¿Í Á¤¹ÐÀÇ·á¿¡ ÁýÁßÇϰí ÀÖ½À´Ï´Ù. ¾Æ½Ã¾ÆÅÂÆò¾çÀº ÀÇ·áºñ Áõ°¡, Á¤ºÎÀÇ ±¸»ó, ÷´Ü Áø´Ü Åø¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡·Î ÀÎÇØ °í¼ºÀå Áö¿ªÀ¸·Î ºÎ»óÇϰí ÀÖ½À´Ï´Ù. ƯÈ÷ Áß±¹°ú Àεµ´Â À¯Àüü ¿¬±¸ ¿ª·®À» È®´ëÇϰí ÀÖÀ¸¸ç, ½ÃÀå ¼ºÀå¿¡ µµ¿òÀÌ µÇ´Â ȯ°æÀ» Á¶¼ºÇϰí ÀÖ½À´Ï´Ù. ¶óƾ¾Æ¸Þ¸®Ä«¿Í Áßµ¿ ½ÃÀåÀº ÀÇ·á¿¡ ´ëÇÑ ÀνÄÀÌ ³ô¾ÆÁö°í ÀÇ·á ÅõÀÚ°¡ Áõ°¡ÇÔ¿¡ µû¶ó Å« ÀáÀç·ÂÀ» º¸ÀÏ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

Ÿ±ê ½ÃÄö½Ì ¹× ¸®½ÃÄö½Ì ½ÃÀå : °æÀï ±¸µµ

Ÿ±ê ½ÃÄö½Ì ¹× ¸®½ÃÄö½Ì ½ÃÀåÀº °æÀïÀÌ Ä¡¿­Çϸç, ¿©·¯ ÁÖ¿ä ±â¾÷ÀÌ ±â¼ú ¹ßÀü°ú Á¦Ç° Á¦°ø¿¡ ÀÖÀ¸¸ç, ÁÖµµ±ÇÀ» Áã°í ÀÖ½À´Ï´Ù. ÀÏ·ç¹Ì³ª, ½á¸ðÇǼŠ»çÀ̾ðƼÇÈ, ·Î½´ µîÀÇ ±â¾÷ÀÌ ÃÖ÷´Ü ½ÃÄö½Ì Ç÷§Æû, ½Ã¾à, ¼­ºñ½º¸¦ Á¦°øÇÕ´Ï´Ù. ÀÏ·ç¹Ì³ª´Â Â÷¼¼´ë ¿°±â¼­¿­ ºÐ¼®(NGS) ±â¼ú·Î ½ÃÀåÀ» µ¶Á¡Çϰí ÀÖÀ¸¸ç, ÀÓ»ó Áø´Ü, ¿¬±¸, ÀǾàǰ °³¹ß¿¡ ³Î¸® Ȱ¿ëµÇ°í ÀÖ½À´Ï´Ù. Thermo Fisher Scientificµµ Áß¿äÇÑ ¿ªÇÒÀ» Çϰí ÀÖÀ¸¸ç, Ÿ±ê ½ÃÄö½Ì¿¡ ÇʼöÀûÀÎ ½ÃÄö½Ì ¼Ö·ç¼Ç°ú »ý¹°Á¤º¸ÇÐ ÅøÀ» Á¦°øÇÕ´Ï´Ù. ·Î½´´Â ÆÄ¿îµ¥ÀÌ¼Ç ¸Þµð½¼(Foundation Medicine)°ú °°Àº Á¤¹Ð Á¾¾çÇÐ Àü¹® ±â¾÷ Àμö¸¦ ÅëÇØ Á¾ÇÕÀûÀÎ À¯Àüü ¼Ö·ç¼ÇÀ» Á¦°øÇϰí ÀÖÀ¸¸ç, ÆÛ½ÃÇÈ ¹ÙÀÌ¿À»çÀ̾ð½º(Pacific Biosciences), Ű¾ÆÁ¨(Qiagen)°ú °°Àº ½Å»ý ±â¾÷Àº ·Õ¸®µå ½ÃÄö½Ì ±â¼ú ¹× »õ·Î¿î ŰƮ·Î ¼­ºñ½º¸¦ °­È­Çϰí ÀÖ½À´Ï´Ù. ¼­ºñ½º¸¦ °­È­Çϰí ÀÖ½À´Ï´Ù. ÀÌ ¿Ü¿¡µµ ¿©·¯ »ý¸í°øÇÐ ±â¾÷ ¹× Çмú±â°üµéÀÌ Èñ±Í À¯ÀüÁúȯ, ¸ÂÃãÀÇ·á, Ç¥ÀûÄ¡·áÁ¦ °³¹ß µî Æ´»õ ºÐ¾ß¿¡ ÁýÁßÇϸ鼭 ½ÃÀå °æÀïÀÌ Ä¡¿­ÇØÁö°í ÀÖ½À´Ï´Ù. Àü·«Àû Á¦ÈÞ, ÇÕº´, Àμö´Â ºü¸£°Ô ÁøÈ­ÇÏ´Â ÀÌ ºÐ¾ß¿¡¼­ ½ÃÀå ÁöÀ§¸¦ °­È­Çϰí Á¦Ç° Æ÷Æ®Æú¸®¿À¸¦ È®ÀåÇϱâ À§ÇÑ ÀϹÝÀûÀÎ Àü·«ÀÔ´Ï´Ù.

¸ñÂ÷

Á¦1Àå Ç¥Àû ½ÃÄö½Ì¡¤¸®½ÃÄö½Ì ½ÃÀå °³¿ä

  • Á¶»ç ¹üÀ§
  • ½ÃÀå ÃßÁ¤ ±â°£

Á¦2Àå °³¿ä

  • ½ÃÀå ³»¿ª
  • °æÀï ÀλçÀÌÆ®

Á¦3Àå Ç¥Àû ½ÃÄö½Ì¡¤¸®½ÃÄö½ÌÀÇ ÁÖ¿ä ½ÃÀå µ¿Çâ

  • ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ
  • ½ÃÀå ¼ºÀå ¾ïÁ¦¿äÀÎ
  • ½ÃÀå ±âȸ
  • ½ÃÀåÀÇ ÇâÈÄ µ¿Çâ

Á¦4Àå Ç¥Àû ½ÃÄö½Ì¡¤¸®½ÃÄö½Ì ½ÃÀå : »ê¾÷ ºÐ¼®

  • PEST ºÐ¼®
  • Porter's Five Forces ºÐ¼®
  • ½ÃÀå ¼ºÀå Àü¸Á : ÁöµµÁ¦ÀÛ
  • ±ÔÁ¦ üÁ¦ÀÇ ºÐ¼®

Á¦5Àå Ç¥Àû ½ÃÄö½Ì¡¤¸®½ÃÄö½Ì ½ÃÀå : ³ô¾ÆÁö´Â ÁöÁ¤ÇÐÀû ±äÀåÀÇ ¿µÇâ

  • COVID-19 ÆÒµ¥¹ÍÀÇ ¿µÇâ
  • ·¯½Ã¾Æ¡¤¿ìÅ©¶óÀ̳ª ÀüÀïÀÇ ¿µÇâ
  • Áßµ¿ ºÐÀïÀÇ ¿µÇâ

Á¦6Àå Ç¥Àû ½ÃÄö½Ì¡¤¸®½ÃÄö½Ì ½ÃÀå ±¸µµ

  • Ç¥Àû ½ÃÄö½Ì¡¤¸®½ÃÄö½Ì ½ÃÀå Á¡À¯À² ºÐ¼®(2024³â)
  • ÁÖ¿ä Á¦Á¶¾÷üº° ³»¿ª µ¥ÀÌÅÍ
    • ±âÁ¸ ±â¾÷ÀÇ ºÐ¼®
    • ½Å±Ô ±â¾÷ÀÇ ºÐ¼®

Á¦7Àå Ç¥Àû ½ÃÄö½Ì¡¤¸®½ÃÄö½Ì ½ÃÀå : ±â¼úº°

  • °³¿ä
    • ºÎ¹®º° Á¡À¯À² ºÐ¼® : ±â¼úº°
    • ½ÃÄö½Ì
    • ¸®½ÃÄö½Ì
      • Àü±â¿µµ¿¿¡ ±â¹ÝÇÑ Àç¹è¿­
      • Â÷¼¼´ë ½ÃÄö½Ì(NGS)
      • ¾î·¹ÀÌ ±â¹Ý Àç¹è¿­

Á¦8Àå Ç¥Àû ½ÃÄö½Ì¡¤¸®½ÃÄö½Ì ½ÃÀå : À¯Çüº°

  • °³¿ä
    • ºÎ¹®º° Á¡À¯À² ºÐ¼® : À¯Çüº°
    • DNA ±â¹Ý Ç¥Àû ½ÃÄö½Ì
    • RNA ±â¹Ý Ç¥Àû ½ÃÄö½Ì

Á¦9Àå Ç¥Àû ½ÃÄö½Ì¡¤¸®½ÃÄö½Ì ½ÃÀå : ¿ëµµº°

  • °³¿ä
    • ºÎ¹®º° Á¡À¯À² ºÐ¼® : ¿ëµµº°
    • ÀÓ»ó ÀÀ¿ë
      • Á¾¾çÇÐ
      • À¯ÀüÀÚ °Ë»ç¡¤½ºÅ©¸®´×
      • °¨¿°Áõ
    • ½Ä¹°¡¤µ¿¹° °úÇÐ
    • ÀǾàǰ °³¹ß
    • ±âŸ

Á¦10Àå Ç¥Àû ½ÃÄö½Ì¡¤¸®½ÃÄö½Ì ½ÃÀå : ÃÖÁ¾»ç¿ëÀÚº°

  • °³¿ä
    • ºÎ¹®º° Á¡À¯À² ºÐ¼® : ÃÖÁ¾»ç¿ëÀÚº°
    • ¿¬±¸±â°ü¡¤Çмú ¼¾ÅÍ
    • Á¦¾à¡¤¹ÙÀÌ¿ÀÅ×Å©³î·¯Áö ±â¾÷
    • º´¿ø¡¤Áø·á¼Ò
    • CRO(ÀÓ»ó½ÃÇè ¼öʱâ°ü ±â°ü)
    • ±âŸ

Á¦11Àå Ç¥Àû ½ÃÄö½Ì¡¤¸®½ÃÄö½Ì ½ÃÀå : Áö¿ªº°

  • ¼­·Ð
  • ºÏ¹Ì
    • °³¿ä
    • ºÏ¹ÌÀÇ ÁÖ¿ä Á¦Á¶¾÷ü
    • ¹Ì±¹
    • ij³ª´Ù
  • À¯·´
    • °³¿ä
    • À¯·´ÀÇ ÁÖ¿ä Á¦Á¶¾÷ü
    • µ¶ÀÏ
    • ¿µ±¹
    • ÇÁ¶û½º
    • ÀÌÅ»¸®¾Æ
    • ½ºÆäÀÎ
    • ³×´ú¶õµå
    • ½º¿þµ§
    • ·¯½Ã¾Æ
    • Æú¶õµå
    • ±âŸ
  • ¾Æ½Ã¾ÆÅÂÆò¾ç(APAC)
    • °³¿ä
    • ¾Æ½Ã¾ÆÅÂÆò¾çÀÇ ÁÖ¿ä Á¦Á¶¾÷ü
    • Áß±¹
    • Àεµ
    • ÀϺ»
    • Çѱ¹
    • È£ÁÖ
    • Àεµ³×½Ã¾Æ
    • ű¹
    • Çʸ®ÇÉ
    • ±âŸ
  • ¶óƾ¾Æ¸Þ¸®Ä«(LATAM)
    • °³¿ä
    • ¶óƾ¾Æ¸Þ¸®Ä«ÀÇ ÁÖ¿ä Á¦Á¶¾÷ü
    • ºê¶óÁú
    • ¸ß½ÃÄÚ
    • ¾Æ¸£ÇîÆ¼³ª
    • ÄÝ·Òºñ¾Æ
    • ±âŸ
  • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«(MEA)
    • °³¿ä
    • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«ÀÇ ÁÖ¿ä Á¦Á¶¾÷ü
    • »ç¿ìµð¾Æ¶óºñ¾Æ
    • ¾Æ¶ø¿¡¹Ì¸®Æ®
    • À̽º¶ó¿¤
    • ÅÍŰ
    • ¾ËÁ¦¸®
    • ÀÌÁýÆ®
    • ±âŸ

Á¦12Àå ÁÖ¿ä º¥´õ ºÐ¼® : Ç¥Àû ½ÃÄö½Ì¡¤¸®½ÃÄö½Ì ¾÷°è

  • °æÀï ´ë½Ãº¸µå
    • °æÀï º¥Ä¡¸¶Å·
    • °æÀï Æ÷Áö¼Å´×
  • ±â¾÷ °³¿ä
    • 10x Genomics, Inc.
    • Agilent Technologies, Inc.
    • BGI Genomics Co., Ltd.
    • Eurofins Scientific
    • Illumina, Inc.
    • Macrogen, Inc.
    • MGI Tech Co., Ltd.
    • Myriad Genetics, Inc.
    • Novogene Corporation
    • Oxford Nanopore Technologies Ltd.
    • Pacific Biosciences of California, Inc.
    • PerkinElmer, Inc.
    • PierianDx
    • QIAGEN NV
    • Roche Sequencing Solutions, Inc.
    • Thermo Fisher Scientific, Inc.
    • Others

Á¦13Àå AnalystViewÀÇ Àü¹æÀ§Àû ºÐ¼®

KSA 25.02.18

REPORT HIGHLIGHT

Targeted Sequencing and Resequencing Market size was valued at US$ 6,124.67 Million in 2024, expanding at a CAGR of 22.6% from 2025 to 2032.

The targeted sequencing and resequencing market focuses on high-throughput sequencing technologies that enable the precise analysis of specific genes or regions of the genome, offering improved resolution compared to whole-genome sequencing. Increased adoption of next-generation sequencing (NGS) techniques in oncology, precision medicine, and genetic research has contributed to market growth. For instance, nearly 40% of researchers in the genomics field reported using targeted sequencing methods for genetic studies in 2023. Factors such as growing demand for personalized medicine, technological advancements in sequencing tools, and increased healthcare investments further propel market growth. However, high costs associated with sequencing equipment and data storage, along with a lack of skilled professionals, may hinder broader adoption. On the other hand, market opportunities exist in developing regions where genetic testing demand is rapidly increasing, along with advancements in cloud-based platforms for better data storage and management. Partnerships between academic institutions and biotech companies are also fostering innovation in targeted sequencing technology.

Targeted Sequencing and Resequencing Market- Market Dynamics

Rising Demand for Personalized Medicine Drives Growth in the Targeted Sequencing and Resequencing Market

The growing demand for personalized medicine is fueling the expansion of the targeted sequencing and resequencing market. Advancements in genomic technologies have enabled precise patient stratification and drug development. The U.S. National Institutes of Health (NIH) has invested significantly in genomics to support personalized therapies, with over $200 million allocated to research in 2020 alone. This surge in research is helping in the development of more accurate diagnostic and therapeutic tools. Additionally, targeted sequencing plays a pivotal role in oncology, with clinical trials showcasing that targeted therapies can enhance survival rates. Moreover, the ongoing initiatives by healthcare institutions to tailor treatments based on individual genetic profiles are driving the adoption of targeted sequencing, helping to achieve better outcomes in cancer and rare genetic disorders.

Targeted Sequencing and Resequencing Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 22.6% over the forecast period (2025-2032)

Based on Technology segmentation, Sequencing Technology was predicted to show maximum market share in the year 2024

Based on Type segmentation, DNA-based Targeted Sequencing was the leading Type in 2024

Based on Application segmentation, Clinical Applications was the leading Application in 2024

On the basis of region, North America was the leading revenue generator in 2024

Targeted Sequencing and Resequencing Market- Segmentation Analysis:

The Global Targeted Sequencing and Resequencing Market is segmented on the basis of Technology, Type, Application, End-User, and Region.

The market is divided into two categories based on Technology: Sequencing and Re-sequencing. Sequencing holds the highest market share due to its broad application in clinical diagnostics and research. Re-sequencing follows closely, offering crucial insights into genetic variations and aiding in personalized medicine and disease management.

The market is divided into two categories based on Type: DNA-based Targeted Sequencing and RNA-based Targeted Sequencing. DNA-based targeted sequencing leads due to its widespread use in genetic analysis and disease detection. RNA-based targeted sequencing follows, offering critical insights into gene expression and regulation, particularly in cancer research and drug development.

Targeted Sequencing and Resequencing Market- Geographical Insights

The targeted sequencing and resequencing market is witnessing strong growth across various regions, driven by advancements in genomics and personalized medicine. North America holds the largest market share, primarily due to the presence of major biotech firms, strong research funding from institutions like the National Institutes of Health (NIH), and the growing adoption of targeted therapies in cancer treatment. The U.S. is a key player, with significant investments in precision medicine, contributing to the region's dominance. Europe also plays a crucial role, with countries like Germany, the UK, and France increasing their focus on genomic research and precision healthcare. The Asia-Pacific region is emerging as a high-growth area, driven by rising healthcare expenditure, government initiatives, and the growing demand for advanced diagnostic tools. China and India are particularly expanding their genetic research capabilities, fostering an environment conducive to market growth. The Latin American and Middle Eastern markets are expected to show significant potential due to increasing awareness and rising healthcare investments.

Targeted Sequencing and Resequencing Market- Competitive Landscape:

The targeted sequencing and resequencing market is highly competitive, with several key players leading the charge in technological advancements and product offerings. Companies like Illumina, Thermo Fisher Scientific, and Roche are at the forefront, offering cutting-edge sequencing platforms, reagents, and services. Illumina dominates the market with its next-generation sequencing (NGS) technology, which is widely used in clinical diagnostics, research, and drug development. Thermo Fisher Scientific also plays a significant role, providing sequencing solutions and bioinformatics tools that are crucial for targeted sequencing. Roche offers comprehensive genomic solutions through its acquisition of companies like Foundation Medicine, focusing on precision oncology. Emerging players such as Pacific Biosciences and Qiagen are enhancing their offerings with long-read sequencing technologies and new kits. In addition to these, several biotechnology firms and academic institutions are focusing on niche applications like rare genetic disorders, personalized medicine, and targeted drug discovery, intensifying market competition. Strategic collaborations, mergers, and acquisitions are common strategies to strengthen market positions and expand product portfolios in this rapidly evolving space.

Recent Developments:

In March 2024, The WHO launched new guidance on targeted next-generation sequencing (NGS) tests for diagnosing drug-resistant tuberculosis, enhancing rapid detection of drug resistance. Additionally, a TB sequencing portal was introduced, featuring over 56,000 sequences to support research and diagnostics.

In May 2024, Baylor Genetics introduced its RNA sequencing test, RNAseq, for Whole Exome and Whole Genome Sequencing (WES/WGS). Additionally, the company reduced the turnaround time for WES and WGS to three weeks, offering reports within five days.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL TARGETED SEQUENCING AND RESEQUENCING MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • 10x Genomics, Inc.
  • Agilent Technologies, Inc.
  • BGI Genomics Co., Ltd.
  • Eurofins Scientific
  • Illumina, Inc.
  • Macrogen, Inc.
  • MGI Tech Co., Ltd.
  • Myriad Genetics, Inc.
  • Novogene Corporation
  • Oxford Nanopore Technologies Ltd.
  • Pacific Biosciences of California, Inc.
  • PerkinElmer, Inc.
  • PierianDx
  • QIAGEN N.V.
  • Roche Sequencing Solutions, Inc.
  • Thermo Fisher Scientific, Inc.
  • Others

GLOBAL TARGETED SEQUENCING AND RESEQUENCING MARKET, BY TECHNOLOGY- MARKET ANALYSIS, 2019 - 2032

  • Sequencing
  • Re-sequencing
  • Electrophoresis-based Resequencing
  • Next-Generation Sequencing (NGS)
  • Array-based Resequencing

GLOBAL TARGETED SEQUENCING AND RESEQUENCING MARKET, BY TYPE- MARKET ANALYSIS, 2019 - 2032

  • DNA-based Targeted Sequencing
  • RNA-based Targeted Sequencing

GLOBAL TARGETED SEQUENCING AND RESEQUENCING MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032

  • Clinical Applications
  • Oncology
  • Genetic Screening and Testing
  • Infectious Diseases
  • Plant & Animal Sciences
  • Drug Development
  • Others

GLOBAL TARGETED SEQUENCING AND RESEQUENCING MARKET, BY END-USER- MARKET ANALYSIS, 2019 - 2032

  • Research Institutes and Academic Centers
  • Pharmaceutical and Biotechnology Companies
  • Hospitals and Clinics
  • Contract Research Organizations (CROs)
  • Others

GLOBAL TARGETED SEQUENCING AND RESEQUENCING MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • The Netherlands
  • Sweden
  • Russia
  • Poland
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Australia
  • Indonesia
  • Thailand
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • UAE
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Targeted Sequencing and Resequencing Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Targeted Sequencing and Resequencing Market Snippet by Technology
    • 2.1.2. Targeted Sequencing and Resequencing Market Snippet by Type
    • 2.1.3. Targeted Sequencing and Resequencing Market Snippet by Application
    • 2.1.4. Targeted Sequencing and Resequencing Market Snippet by End-User
    • 2.1.5. Targeted Sequencing and Resequencing Market Snippet by Country
    • 2.1.6. Targeted Sequencing and Resequencing Market Snippet by Region
  • 2.2. Competitive Insights

3. Targeted Sequencing And Resequencing Key Market Trends

  • 3.1. Targeted Sequencing and Resequencing Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Targeted Sequencing and Resequencing Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Targeted Sequencing and Resequencing Market Opportunities
  • 3.4. Targeted Sequencing and Resequencing Market Future Trends

4. Targeted Sequencing And Resequencing Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Targeted Sequencing And Resequencing Market: Impact of Escalating Geopolitical Tensions

  • 5.1. Impact of COVID-19 Pandemic
  • 5.2. Impact of Russia-Ukraine War
  • 5.3. Impact of Middle East Conflicts

6. Targeted Sequencing and Resequencing Market Landscape

  • 6.1. Targeted Sequencing and Resequencing Market Share Analysis, 2024
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Targeted Sequencing and Resequencing Market - By Technology

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Technology, 2024 & 2032 (%)
    • 7.1.2. Sequencing
    • 7.1.3. Re-sequencing
      • 7.1.3.1. Electrophoresis-based Resequencing
      • 7.1.3.2. Next-Generation Sequencing (NGS)
      • 7.1.3.3. Array-based Resequencing

8. Targeted Sequencing and Resequencing Market - By Type

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Type, 2024 & 2032 (%)
    • 8.1.2. DNA-based Targeted Sequencing
    • 8.1.3. RNA-based Targeted Sequencing

9. Targeted Sequencing and Resequencing Market - By Application

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Application, 2024 & 2032 (%)
    • 9.1.2. Clinical Applications
      • 9.1.2.1. Oncology
      • 9.1.2.2. Genetic Screening and Testing
      • 9.1.2.3. Infectious Diseases
    • 9.1.3. Plant & Animal Sciences
    • 9.1.4. Drug Development
    • 9.1.5. Others

10. Targeted Sequencing and Resequencing Market - By End-User

  • 10.1. Overview
    • 10.1.1. Segment Share Analysis, By End-User, 2024 & 2032 (%)
    • 10.1.2. Research Institutes and Academic Centers
    • 10.1.3. Pharmaceutical and Biotechnology Companies
    • 10.1.4. Hospitals and Clinics
    • 10.1.5. Contract Research Organizations (CROs)
    • 10.1.6. Others

11. Targeted Sequencing And Resequencing Market- By Geography

  • 11.1. Introduction
    • 11.1.1. Segment Share Analysis, By Geography, 2024 & 2032 (%)
  • 11.2. North America
    • 11.2.1. Overview
    • 11.2.2. Targeted Sequencing And Resequencing Key Manufacturers in North America
    • 11.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.2.4. North America Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.2.5. North America Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 11.2.6. North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.2.7. North America Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.2.8. U.S.
      • 11.2.8.1. Overview
      • 11.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.2.8.3. U.S. Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.2.8.4. U.S. Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.2.8.5. U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.2.8.6. U.S. Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.2.9. Canada
      • 11.2.9.1. Overview
      • 11.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.2.9.3. Canada Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.2.9.4. Canada Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.2.9.5. Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.2.9.6. Canada Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 11.3. Europe
    • 11.3.1. Overview
    • 11.3.2. Targeted Sequencing And Resequencing Key Manufacturers in Europe
    • 11.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.3.4. Europe Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.3.5. Europe Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 11.3.6. Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.3.7. Europe Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.8. Germany
      • 11.3.8.1. Overview
      • 11.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.8.3. Germany Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.3.8.4. Germany Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.3.8.5. Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.8.6. Germany Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.9. UK
      • 11.3.9.1. Overview
      • 11.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.9.3. UK Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.3.9.4. UK Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.3.9.5. UK Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.9.6. UK Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.10. France
      • 11.3.10.1. Overview
      • 11.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.10.3. France Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.3.10.4. France Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.3.10.5. France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.10.6. France Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.11. Italy
      • 11.3.11.1. Overview
      • 11.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.11.3. Italy Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.3.11.4. Italy Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.3.11.5. Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.11.6. Italy Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.12. Spain
      • 11.3.12.1. Overview
      • 11.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.12.3. Spain Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.3.12.4. Spain Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.3.12.5. Spain Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.12.6. Spain Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.13. The Netherlands
      • 11.3.13.1. Overview
      • 11.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.13.3. The Netherlands Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.3.13.4. The Netherlands Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.3.13.5. The Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.13.6. The Netherlands Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.14. Sweden
      • 11.3.14.1. Overview
      • 11.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.14.3. Sweden Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.3.14.4. Sweden Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.3.14.5. Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.14.6. Sweden Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.15. Russia
      • 11.3.15.1. Overview
      • 11.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.15.3. Russia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.3.15.4. Russia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.3.15.5. Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.15.6. Russia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.16. Poland
      • 11.3.16.1. Overview
      • 11.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.16.3. Poland Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.3.16.4. Poland Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.3.16.5. Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.16.6. Poland Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.17. Rest of Europe
      • 11.3.17.1. Overview
      • 11.3.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.17.3. Rest of the Europe Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.3.17.4. Rest of the Europe Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.3.17.5. Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.17.6. Rest of the Europe Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 11.4. Asia Pacific (APAC)
    • 11.4.1. Overview
    • 11.4.2. Targeted Sequencing And Resequencing Key Manufacturers in Asia Pacific
    • 11.4.3. APAC Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.4.4. APAC Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.4.5. APAC Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 11.4.6. APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.4.7. APAC Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.8. China
      • 11.4.8.1. Overview
      • 11.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.8.3. China Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.4.8.4. China Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.4.8.5. China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.8.6. China Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.9. India
      • 11.4.9.1. Overview
      • 11.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.9.3. India Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.4.9.4. India Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.4.9.5. India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.9.6. India Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.10. Japan
      • 11.4.10.1. Overview
      • 11.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.10.3. Japan Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.4.10.4. Japan Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.4.10.5. Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.10.6. Japan Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.11. South Korea
      • 11.4.11.1. Overview
      • 11.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.11.3. South Korea Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.4.11.4. South Korea Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.4.11.5. South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.11.6. South Korea Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.12. Australia
      • 11.4.12.1. Overview
      • 11.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.12.3. Australia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.4.12.4. Australia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.4.12.5. Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.12.6. Australia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.13. Indonesia
      • 11.4.13.1. Overview
      • 11.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.13.3. Indonesia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.4.13.4. Indonesia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.4.13.5. Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.13.6. Indonesia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.14. Thailand
      • 11.4.14.1. Overview
      • 11.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.14.3. Thailand Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.4.14.4. Thailand Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.4.14.5. Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.14.6. Thailand Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.15. Philippines
      • 11.4.15.1. Overview
      • 11.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.15.3. Philippines Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.4.15.4. Philippines Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.4.15.5. Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.15.6. Philippines Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.16. Rest of APAC
      • 11.4.16.1. Overview
      • 11.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.16.3. Rest of APAC Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.4.16.4. Rest of APAC Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.4.16.5. Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.16.6. Rest of APAC Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 11.5. Latin America (LATAM)
    • 11.5.1. Overview
    • 11.5.2. Targeted Sequencing And Resequencing Key Manufacturers in Latin America
    • 11.5.3. LATAM Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.5.4. LATAM Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.5.5. LATAM Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 11.5.6. LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.5.7. LATAM Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.5.8. Brazil
      • 11.5.8.1. Overview
      • 11.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.8.3. Brazil Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.5.8.4. Brazil Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.5.8.5. Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.8.6. Brazil Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.5.9. Mexico
      • 11.5.9.1. Overview
      • 11.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.9.3. Mexico Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.5.9.4. Mexico Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.5.9.5. Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.9.6. Mexico Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.5.10. Argentina
      • 11.5.10.1. Overview
      • 11.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.10.3. Argentina Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.5.10.4. Argentina Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.5.10.5. Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.10.6. Argentina Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.5.11. Colombia
      • 11.5.11.1. Overview
      • 11.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.11.3. Colombia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.5.11.4. Colombia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.5.11.5. Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.11.6. Colombia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.5.12. Rest of LATAM
      • 11.5.12.1. Overview
      • 11.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.12.3. Rest of LATAM Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.5.12.4. Rest of LATAM Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.5.12.5. Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.12.6. Rest of LATAM Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 11.6. Middle East and Africa (MEA)
    • 11.6.1. Overview
    • 11.6.2. Targeted Sequencing And Resequencing Key Manufacturers in Middle East and Africa
    • 11.6.3. MEA Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.6.4. MEA Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.6.5. MEA Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 11.6.6. MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.6.7. MEA Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.8. Saudi Arabia
      • 11.6.8.1. Overview
      • 11.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.8.3. Saudi Arabia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.6.8.4. Saudi Arabia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.6.8.5. Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.8.6. Saudi Arabia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.9. United Arab Emirates
      • 11.6.9.1. Overview
      • 11.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.9.3. United Arab Emirates Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.6.9.4. United Arab Emirates Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.6.9.5. United Arab Emirates Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.9.6. United Arab Emirates Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.10. Israel
      • 11.6.10.1. Overview
      • 11.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.10.3. Israel Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.6.10.4. Israel Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.6.10.5. Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.10.6. Israel Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.11. Turkey
      • 11.6.11.1. Overview
      • 11.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.11.3. Turkey Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.6.11.4. Turkey Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.6.11.5. Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.11.6. Turkey Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.12. Algeria
      • 11.6.12.1. Overview
      • 11.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.12.3. Algeria Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.6.12.4. Algeria Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.6.12.5. Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.12.6. Algeria Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.13. Egypt
      • 11.6.13.1. Overview
      • 11.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.13.3. Egypt Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.6.13.4. Egypt Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.6.13.5. Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.13.6. Egypt Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.14. Rest of MEA
      • 11.6.14.1. Overview
      • 11.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.14.3. Rest of MEA Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.6.14.4. Rest of MEA Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.6.14.5. Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.14.6. Rest of MEA Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)

12. Key Vendor Analysis- Targeted Sequencing And Resequencing Industry

  • 12.1. Competitive Dashboard
    • 12.1.1. Competitive Benchmarking
    • 12.1.2. Competitive Positioning
  • 12.2. Company Profiles
    • 12.2.1. 10x Genomics, Inc.
    • 12.2.2. Agilent Technologies, Inc.
    • 12.2.3. BGI Genomics Co., Ltd.
    • 12.2.4. Eurofins Scientific
    • 12.2.5. Illumina, Inc.
    • 12.2.6. Macrogen, Inc.
    • 12.2.7. MGI Tech Co., Ltd.
    • 12.2.8. Myriad Genetics, Inc.
    • 12.2.9. Novogene Corporation
    • 12.2.10. Oxford Nanopore Technologies Ltd.
    • 12.2.11. Pacific Biosciences of California, Inc.
    • 12.2.12. PerkinElmer, Inc.
    • 12.2.13. PierianDx
    • 12.2.14. QIAGEN N.V.
    • 12.2.15. Roche Sequencing Solutions, Inc.
    • 12.2.16. Thermo Fisher Scientific, Inc.
    • 12.2.17. Others

13. 360 Degree AnalystView

14. Appendix

  • 14.1. Research Methodology
  • 14.2. References
  • 14.3. Abbreviations
  • 14.4. Disclaimer
  • 14.5. Contact Us
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦